The processed C‐terminus of AvrRps4 effector suppresses plant immunity via targeting multiple WRKYs
Journal of Integrative Plant Biology · 2024
DOI: 10.1111/jipb.13710 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Integrative Plant Biology, 2024. Verfasst von Quang-Minh Nguyen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Applied Life Science (BK21 Four Program), Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinj…. Hauptthemen laut MEDLINE: Plant Immunity, Arabidopsis, Arabidopsis Proteins, Pseudomonas syringae. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea, Rural Development Administration.
Abstract (Originalsprache)
Pathogens generate and secrete effector proteins to the host plant cells during pathogenesis to promote virulence and colonization. If the plant carries resistance (R) proteins that recognize pathogen effectors, effector‐triggered immunity (ETI) is activated, resulting in a robust immune response and hypersensitive response (HR). The bipartite effector AvrRps4 from Pseudomonas syringae pv. pisi has been well studied in terms of avirulence function. In planta , AvrRps4 is processed into two parts. The C‐terminal fragment of AvrRps4 (AvrRps4 C ) induces HR in turnip and is recognized by the paired resistance proteins AtRRS1/AtRPS4 in Arabidopsis. Here, we show that AvrRps4 C targets a group of Arabidopsis WRKY, including WRKY46, WRKY53, WRKY54, and WRKY70, to induce its virulence function. Indeed, AvrRps4 C suppresses the general binding and transcriptional activities of immune‐positive regulator WRKY54 and WRKY54‐mediated resistance. AvrRps4 C interferes with WRKY54's binding activity to target gene SARD1 in vitro , suggesting WRKY54 is sequestered from the SARD1 promoter by AvrRps4 C . Through the interaction of AvrRps4 C with four WRKYs, AvrRps4 enhances the formation of homo‐/heterotypic complexes of four WRKYs and sequesters them in the cytoplasm, thus inhibiting their function in plant immunity. Together, our results provide a detailed virulence mechanism of AvrRps4 through its C‐terminus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Applied Life Science (BK21 Four Program), Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, 52828, Korea.
- Department of Life Science, Sogang University, Seoul, 04107, Korea.
- Department of Plant Biotechnology, Korea University, Seoul, 02841, Korea.
- Division of Plant Science and Technology, Christopher S. Bond Life Sciences Center and Interdisciplinary Plant Group, University of Missouri, Columbia, 65211, Missouri, USA.
- Division of Life Science and Research Institute of Molecular Alchemy, Gyeongsang National University, Jinju, 52828, Korea.
Förderung
- National Research Foundation of Korea
- Rural Development Administration
Zitieren
APA
Nguyen, Q. M., Iswanto, A. B. B., Kang, H., Moon, J., Phan, K. A. T., Son, G. H., Suh, M. C., Chung, E. H., Gassmann, W., & Kim, S. H. (2024). The processed C‐terminus of AvrRps4 effector suppresses plant immunity via targeting multiple WRKYs. Journal of Integrative Plant Biology. https://doi.org/10.1111/jipb.13710
Vancouver
Nguyen QM, Iswanto ABB, Kang H, Moon J, Phan KAT, Son GH, et al. The processed C‐terminus of AvrRps4 effector suppresses plant immunity via targeting multiple WRKYs. Journal of Integrative Plant Biology. 2024. doi:10.1111/jipb.13710
BibTeX
@article{Nguyen2024,
author = {Nguyen, Quang-Minh and Iswanto, Arya Bagus Boedi and Kang, Hobin and Moon, Jiyun and Phan, Kieu Anh Thi and Son, Geon Hui and Suh, Mi Chung and Chung, Eui-Hwan and Gassmann, Walter and Kim, Sang Hee},
title = {The processed C‐terminus of AvrRps4 effector suppresses plant immunity via targeting multiple WRKYs},
journal = {Journal of Integrative Plant Biology},
year = {2024},
doi = {10.1111/jipb.13710}
}
EUVIMED